Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell cultureAnna Lahti, Katriina Aalto‐Setälä, Shinya Yamanaka et al.|Disease Models & Mechanisms|2011Cited by 291
Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Reveals Early and Delayed AfterdepolarizationsKirsi Kujala, Katriina Aalto‐Setälä, Heikki Swan et al.|PLoS ONE|2012Cited by 135
Antiarrhythmic Effects of Dantrolene in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia and Replication of the Responses Using iPSC ModelsKirsi Penttinen, Katriina Aalto‐Setälä, Heikki Swan et al.|PLoS ONE|2015Cited by 105
Distinct electrophysiological and mechanical beating phenotypes of long QT syndrome type 1-specific cardiomyocytes carrying different mutationsAnna Kiviaho, Katriina Aalto‐Setälä, Antti Ahola et al.|IJC Heart & Vasculature|2015Cited by 42
Antiarrhythmic Effects of Carvedilol and Flecainide in Cardiomyocytes Derived from Catecholaminergic Polymorphic Ventricular Tachycardia PatientsRisto-Pekka Pölönen, Katriina Aalto‐Setälä, Kirsi Penttinen et al.|Stem Cells International|2018Cited by 31